Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion

Endocrinology

Volumn 146, Issue 10, 2005, Pages 4445-4455

  Russo, V C ^a   Schutt B S ^a,b   Andaloro, E ^a   Ymer, S I ^a   Hoeflich, A ^c   Ranke, M B ^b   Bach, L A ^a   Werther, G A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; ARGINYLGLYCYLGLUTAMIC ACID; HEPARIN BINDING PROTEIN; INTEGRIN; MUTANT PROTEIN; PEPTIDE; SOMATOMEDIN BINDING PROTEIN 2; TRITIUM; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CANCER CONTROL; CANCER GROWTH; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

BASE SEQUENCE; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; DNA PRIMERS; EXTRACELLULAR MATRIX; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; KINETICS; MUTAGENESIS, SITE-DIRECTED; NEOPLASM INVASIVENESS; NEUROBLASTOMA; PROTEIN BINDING;

EID: 24944587144     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2005-0467     Document Type: Article

References (67)

1. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
2. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
3. Hoeflich A, Schmidt P, Foll J, Rottmann O, Weber MM, Kolb HJ, Pirchner F, Wolf E 1998 Altered growth of mice divergently selected for body weight is associated with complex changes in the growth hormone/insulin-like growth factor system. Growth Horm IGF Res 8:113-123
4. Hoeflich A, Wu M, Mohan S, Foll J, Wanke R, Froehlich T, Arnold GJ, Lahm H, Kolb HJ, Wolf E 1999 Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 140:5488-5496
5. Pereira JJ, Meyer T, Docherty SE, Reid HH, Marshall J, Thompson EW, Rossjohn J, Price JT 2004 Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with αvβ3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res 64:977-984
6. Moore MG, Wetterau LA, Francis MJ, Peehl DM, Cohen P 2003 Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells. Int J Cancer 105:14-19
7. Song SW, Fuller GN, Khan A, Kong S, Shen W, Taylor E, Ramdas L, Lang FF, Zhang W 2003 IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl Acad Sci USA 100:13970-13975
8. Schutt BS, Langkamp M, Rauschnabel U, Ranke MB, Elmlinger MW 2004 Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J Mol Endocrinol 32:859-868
9. Wang H, Shen W, Huang H, Huang H, Hu L, Ramdas L, Zhou YH, Liao WS, Fuller GN, Zhang W 2003 Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res 63:4315-4321
10. Zhang W, Wang H, Song SW, Fuller GN 2002 Insulin-like growth factor binding protein 2: gene expression microarrays and the hypothesis-generation paradigm. Brain Pathol 12:87-94
11. Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi OP, Kononen J 2000 Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 60:6617-6622
12. Nordqvist AC, Peyrard M, Pettersson H, Mathiesen T, Collins VP, Dumanski JP, Schalling M 1997 A high ratio of insulin-like growth factor II/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas. Cancer Res 57:2611-2614
13. Elmlinger MW, Deininger MH, Schuett BS, Meyermann R, Duffner F, Grote EH, Ranke MB 2001 In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade. Endocrinology 142:1652-1658
14. Wang H, Shen SS, Diwan AH, Zhang W, Fuller GN, Prieto VG 2003 Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions. J Cutan Pathol 30:599-605
15. Russo VC, Bach LA, Fosang AJ, Baker NL, Werther GA 1997 Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Endocrinology 138:4858-4867
16. Cardin AD, Weintraub HJ 1989 Molecular modeling of protein- glycosaminoglycan interactions. Arteriosclerosis 9:21-32
17. Russo VC, Rekaris G, Baker NL, Bach LA, Werther GA 1999 Basic fibroblast growth factor induces proteolysis of secreted and cell membrane-associated insulin-like growth factor binding protein-2 in human neuroblastoma cells. Endocrinology 140:3082-3090
18. Kricker JA, Towne CL, Firth SM, Herington AC, Upton Z 2003 Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Endocrinology 144:2807-2815
19. Marinaro JA, Neumann GM, Russo VC, Leeding KS, Bach LA 2000 Oglycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis. Eur J Biochem 267:5378-5386
20. Ruoslahti E, Pierschbacher MD 1987 New perspectives in cell adhesion: RGD and integrins. Science 238:491-497
21. Hoeflich A, Reisinger R, Vargas GA, Elmlinger MW, Schuett B, Jehle PM, Renner-Muller I, Lahm H, Russo VC, Wolf E 2002 Mutation of the RGD sequence does not affect plasma membrane association and growth inhibitory effects of elevated IGFBP-2 in vivo. FEBS Lett 523:63-67
22. van Golen CM, Castle VP, Feldman EL 2000 IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma. Cell Death Differ 7:654-665
23. Russo VC, Kobayashi K, Najdovska S, Baker NL, Werther GA 2004 Neuronal protection from glucose deprivation via modulation of glucose transport and inhibition of apoptosis: a role for the insulin-like growth factor system. Brain Res 1009:40-53
24. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M 1986 Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138-143
25. Elmlinger MW, Wimmer K, Biemer E, Blum WF, Ranke MB, Dannecker GE 1996 Insulin-like growth factor binding protein 2 is differentially expressed in leukaemic B- and T-cell lines. Growth Regul 6:152-157
26. Ho PJ, Baxter RC 1997 Characterization of truncated insulin-like growth factor-binding protein-2 in human milk. Endocrinology 138:3811-3818
27. McCaig C, Perks CM, Holly JM 2002 Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J Cell Sci 115:4293-4303
28. Booth BA, Boes M, Andress DL, Dake BL, Kiefer MC, Maack C, Linhardt RJ, Bar K, Caldwell EE, Weiler J, Bar RS 1995 IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. Growth Regul 5:1-17
29. Gui Y, Murphy LJ 2001 Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma. J Clin Endocrinol Metab 86:2104-2110
30. Nam T, Moralez A, Clemmons D 2002 Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions. Endocrinology 143:30-36
31. Arai T, Clarke J, Parker A, Busby Jr W, Nam T, Clemmons DR 1996 Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin. J Biol Chem 271:6099-6106
32. Firth SM, Ganeshprasad U, Baxter RC 1998 Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3. J Biol Chem 273:2631-2638
33. Janet T, Ludecke G, Otten U, Unsicker K 1995 Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: correlation with expression of growth factors and growth factor receptors. J Neurosci Res 40:707-715
34. Russo VC, Metaxas S, Kobayashi K, Harris M, Werther GA 2004 Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 145:4103-4112
35. Hoeflich A, Fettscher O, Preta G, Lahm H, Kolb HJ, Wolf E, Weber MM 2003 Increased activity of catalase in tumor cells overexpressing IGFBP-2. Horm Metab Res 35:816-821
36. Babajko S, Binoux M 1996 Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells. Eur J Endocrinol 134:474-480
37. Martin DM, Feldman EL 1993 Regulation of insulin-like growth factor-II expression and its role in autocrine growth of human neuroblastoma cells. J Cell Physiol 155:290-300
38. Matthews CC, Feldman EL 1996 Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J Cell Physiol 166:323-331
39. Russo VC, Andaloro E, Fornaro SA, Najdovska S, Newgreen DF, Bach LA, Werther GA 2004 Fibroblast growth factor-2 over-rides insulin-like growth factor-I induced proliferation and cell survival in human neuroblastoma cells. J Cell Physiol 199:371-380
40. Scarpa S, Modesti A, Triche TJ 1987 Extracellular matrix synthesis by undifferentiated childhood tumor cell lines. Am J Pathol 129:74-85
41. Hutchinson R, Fligiel S, Appleyard J, Varani J, Wicha M 1989 Attachment of neuroblastoma cells to extracellular matrix: correlation with metastatic capacity. J Lab Clin Med 113:561-568
42. Gladson CL, Dennis C, Rotolo TC, Kelly DR, Grammer JR 1997 Vitronectin expression in differentiating neuroblastic tumors: integrin αvβ5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells. Am J Pathol 150:1631-1646
43. Stewart DA, Cooper CR, Sikes RA 2004 Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod Biol Endocrinol 2:2
44. DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, Raz A, Matrisian LM, Sloane BF, Noel A, Hendrix MJ, Coussens L, Padarathsingh M 2004 Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am J Pathol 164:1131-1139
45. Campbell PG, Andress DL 1997 Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I binding. Am J Physiol 273:E1005-E1013
46. Nam TJ, Busby Jr W, Clemmons DR 1997 Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I. Endocrinology 138:2972-2978
47. Nam TJ, Busby Jr WH, Rees C, Clemmons DR 2000 Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. Endocrinology 141:1100-1106
48. Shimasaki S, Ling N 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 3:243-266
49. Korc-Grodzicki B, Ren N, Hilf R 1996 Effects of estradiol on the expression and production of IGFBP-2 by R3230AC mammary tumor cells. Oncol Res 8:473-483
50. Ho PJ, Baxter RC 1997 Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol (Oxf) 46:333-342
51. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS, Plymate SR 1996 Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. J Clin Endocrinol Metab 81:411-420
52. Mohnike KL, Kluba U, Mittler U, Aumann V, Vorwerk P, Blum WF 1996 Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia. Eur J Pediatr 155:81-86
53. Duan C, Ding J, Li Q, Tsai W, Pozios K 1999 Insulin-like growth factor binding protein 2 is a growth inhibitory protein conserved in zebrafish. Proc Natl Acad Sci USA 96:15274-15279
54. Hoeflich A, Reisinger R, Schuett BS, Elmlinger MW, Russo VC, Vargas GA, Jehle PM, Lahm H, Renner-Muller I, Wolf E 2004 Peri/nuclear localization of intact insulin-like growth factor binding protein-2 and a distinct carboxylterminal IGFBP-2 fragment in vivo. Biochem Biophys Res Commun 324:705-710
55. Liotta LA 2001 An attractive force in metastasis. Nature 410:24-25
56. Liotta LA, Kohn EC 2001 The microenvironment of the tumour-host interface. Nature 411:375-379
57. Jin H, Varner J 2004 Integrins: roles in cancer development and as treatment targets. Br J Cancer 90:561-565
58. Ramnath N, Creaven PJ 2004 Matrix metalloproteinase inhibitors. Curr Oncol Rep 6:96-102
59. Zhang D, Samani AA, Brodt P 2003 The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis. Horm Metab Res 35:802-808
60. Nagle RB 2004 Role of the extracellular matrix in prostate carcinogenesis. J Cell Biochem 91:36-40
61. Jackson RL, Busch SJ, Cardin AD 1991 Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 71:481-539
62. Hojilla CV, Mohammed FF, Khokha R 2003 Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 89:1817-1821
63. Nordqvist AC, Mathiesen T 2002 Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness. J Neurooncol 57:19-26
64. Shariat SF, Lamb DJ, Kattan MW, Nguyen C, Kim J, Beck J, Wheeler TM, Slawin KM 2002 Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. J Clin Oncol 20:833-841
65. Baron-Hay S, Boyle F, Ferrier A, Scott C 2004 Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clin Cancer Res 10:1796-1806
66. Fowlkes JL, Thrailkill KM, George-Nascimento C, Rosenberg CK, Serra DM 1997 Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation. Endocrinology 138:2280-2285
67. Headey SJ, Keizer DW, Yao S, Brasier G, Kantharidis P, Bach LA, Norton RS 2004 C-terminal domain of insulin-like growth factor binding protein-6: structure and interaction with insulin-like growth factor-II. Mol Endocrinol 18:2740-2750